CTT Pharmaceutical Holdings, Inc. announced several additions to its Board of Directors and management team. Effective immediately, Robert (Bob) Allen has been appointed as CFO, Dana Buschmann has been appointed as Director (Independent), and Marc Lakmaaker has been named strategic advisor to the Company. Dana worked for several patent law firms in Washington D.C. from 2003 - 2011 and was Patent Management Attorney for the University of Texas Medical Branch at Galveston from 2011 - 2017.

She currently owns and operates DZ Buschmann Law in Edmonton, Alberta. Dana will be working closely with management on the strengthening of the Company's IP portfolio. Appointment of Marc Lakmaaker as Strategic Advisor Marc is a high-profile executive with over 20 years of capital markets, management and communications experience.

He has deep knowledge of the cannabis industry, with a strong network of analysts, investors, influencers and industry participants.